Most of the guidelines and further reading articles in each section of Pharmaceutical Care Made Easy are available online, indicated by the word "ONLINE" after the reference. These references are listed below. They give the latest guidance on the management of the common conditions covered, without the need for searching the Internet.

Updates to this list will be posted here every six months.

General documents and sites

1. Audit Commission. A Spoonful of Sugar - Medicines Management in NHS Hospitals. London: Audit Commission; 2001.
   (view website)
2. Department of Health. An Organisation with a Memory. Report of an expert working group on learning from adverse events in the NHS chaired by the Chief Medical Officer. London: The Stationery Office; 2000.
   (view website)
3. Strand L. Building a practice in pharmaceutical care. Pharm J 1998; 260: 874-876.
   (view website)
4. Simpson D. What is medicines management and what is pharmaceutical care? Pharm J 2001; 266: 150.
   (view website)
5. Current British National Formulary
   (view website)
6. Prescriber website
   (view website)
7. National Prescribing Centre website
   (view website)
8. National Institute for Health and Clinical Excellence website
   (view website)
9. Scottish Intercollegiate Guidelines Network website
   (view website)
10. Pharmaceutical Journal Continuing Education articles.
    (view website)
11. Medicines Partnership website
    (view website)
12. Caldwell NA, Sexton JA, Green CF, Farrar K. Sowing the seeds of pharmaceutical care: developments in undergraduate clinical teaching at Liverpool School of Pharmacy. Pharm J 2001; 267: 721-723.
    (view website)

Cardiology

1. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634-40.
   (view website)
2. National Institute for Clinical Excellence. Clinical Guideline 34: Management of Hypertension in Adults in Primary Care. London: NICE; 2006.
   (view website)
3. Department of Health. National Service Framework for Coronary Heart Disease. London: Department of Health; 2000.
   (view website)
4. Williams H, Stevens M. Heart disease (2) Chronic stable angina. Pharm J 2002; 269: 363-365.
   (view website)
5. Scottish Intercollegiate Guidelines Network. SIGN 51: The Management Of Stable Angina. Edinburgh: Scottish Intercollegiate Guidelines Network; 2001.
   (view website)
6. Williams H, Kearney M. Heart disease (1) Chronic heart failure. Pharm J 2002; 269: 325-327.
   (view website)
7. National Institute for Clinical Excellence. Clinical Guideline 5: Management of Chronic Heart Failure in Adults in Primary and Secondary Care. London: NICE; 2003.
   (view website)
8. Williams H, McRobbie D, Davies R. Primary prevention of heart disease. Pharm J 2003; 270: 86-88.
   (view website)
9. Stevens M, Williams H. Secondary prevention of heart disease. Pharm J 2002; 269: 784-786.
   (view website)
10. National Institute for Clinical Excellence. Clinical Guideline A: Prophylaxis for Patients who have Experienced a Myocardial Infarction. London: NICE; 2001.
    (view website)
11. JBS2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91 (Suppl. V): v1-v52.
    (view website)
12. National Institute for Clinical Excellence. Technology Appraisal 94. Statins for the prevention of cardiovascular events. London: NICE; 2006.
    (view website)

Respiratory medicine

1. National Institute for Clinical Excellence. Clinical Guideline 4: Chronic Obstructive Pulmonary Disease - Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. London: NICE; 2004.
   (view website)
2. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. London and Edinburgh: British Thoracic Society and Scottish Intercollegiate Guidelines Network; 2004.
   (view website)
3. National Institute for Clinical Excellence. Technology Appraisal 38: Inhaler Devices for Routine Treatment of Chronic Asthma in Older Children (aged 5-15 years). London: NICE; 2002.
   (view website)

Endocrinology and rheumatology

1. National Institute for Clinical Excellence. Clinical Guideline 15: Type 1 Diabetes - Diagnosis and Management of Type 1 Diabetes in Adults (2004). London: NICE; 2004.
   (view website)
2. National Institute for Clinical Excellence. Clinical Guideline H: Type 2 Diabetes - Management of Blood Pressure and Blood Lipids. London: NICE; 2002.
   (view website)
3. National Institute for Clinical Excellence. Clinical guideline F: Management of Type 2 Diabetes - Renal Disease, Prevention and Early Management. London: NICE; 2002.
   (view website)
4. National Institute for Clinical Excellence. Clinical Guideline G: Management of Type 2 Diabetes - Managing Blood Glucose Levels. London: NICE; 2002.
   (view website)
5. National Institute for Clinical Excellence. Technology Appraisal 63: Full Guidance on the use of Glitazones for the Treatment of Type 2 Diabetes. London: NICE; 2003.
   (view website)
6. National Institute for Clinical Excellence. Technology Appraisal 53: The Clinical Effectiveness and Cost Effectiveness of Long Acting Insulin Analogues for Diabetes. London: NICE; 2002.
   (view website)
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
   (view website)
8. National Prescribing Centre. Drug management of type 2 diabetes: summary. MeReC Bulletin 2004; 15: 1-4.
   (view website)
9. Green CF. Using TNF\alpha; technology to treat rheumatoid arthritis. Hosp Pharm 2004; 1: 286-91.
   (view website)
10. Parkinson S, Alldred A. Drug regimens for rheumatoid arthritis. Hosp Pharm 2002; 9: 11-15.
    (view website)
11. Buch M, Emery P. The aetiology and pathogenesis of rheumatoid arthritis. Hosp Pharm 2002; 9: 5-10.
    (view website)
12. Bayraktar A, Hudson S, Watson A, Fraser S. Pharmaceutical care (7): Arthritis. Pharm J 2000; 264: 57-68.
    (view website)
13. Young A. Rheumatoid arthritis: current approaches to management. Prescriber 2004; 15: 48-55.
    (view website)
14. National Institute for Clinical Excellence. Technology Appraisal 36: The Clinical Effectiveness and Cost Effectiveness of Etanercept and Infliximab for Rheumatoid Arthritis and Juvenile Poly-articular Idiopathic Arthritis. London: NICE; 2002.
    (view website)
15. National Institute for Clinical Excellence. Technology Appraisal 72: The Clinical Effectiveness and Cost Effectiveness of Anakinra for Rheumatoid Arthritis. London: NICE; 2003.
    (view website)

Nephrology and renal transplant

1. Sexton JA. Drug use and dosing in the renally impaired adult. Pharm J 2003; 271: 231-234.
   (view website)
2. Morlidge C, Richards T. Managing chronic renal disease. Pharm J 2001; 266: 655-657.
   (view website)
3. Currie A, O'Brien P. Renal replacement therapies. Pharm J 2001; 266: 679-683.
   (view website)
4. Sexton JA, Vincent M. Managing anaemia in renal failure. Pharm J 2004; 273: 603-605.
   (view website)
5. Sexton JA, Vincent M. Remedying calcium and phosphate problems in chronic kidney disease. Pharm J 2004; 274: 561-564.
   (view website)
6. Department of Health. Renal Specific Management of Medicines. London: Department of Health; 2004.
   (view website)
7. Renal Association. Treatment of Adults and Children with Renal Failure: Standards and Audit Measures, 3rd edn. London: Royal College of Physicians of London and the Renal Association; 2002.
   (view website)
8. National Kidney Foundation. Kidney Dialysis Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. New York: National Kidney Foundation; 2005.
   (view website)
9. Lee M, Devaney A. Immunosuppression after adult renal transplant. Pharm J 2001; 266: 754-758.
   (view website)
10. National Institute for Clinical Excellence. Technology Appraisal 85: The Clinical Effectiveness and Cost Effectiveness of Immuno-suppressive Therapy for Renal Transplantation. London: NICE; 2004.
    (view website)

Gastroenterology

1. Harris A, Misiewicz JJ. ABC of the upper gastrointestinal tract: Management of Helicobacter pylori infection. BMJ 2001; 323: 1047-50.
   (view website)
2. de Caestecker J. ABC of the upper gastrointestinal tract: Oesophagus: Heartburn. BMJ 2001; 323: 736-739.
   (view website)
3. Veysey M, Wilkinson M. Today's management of dyspepsia and ulcers. Prescriber 2003; 14: 52-62.
   (view website)
4. National Institute for Clinical Excellence. Clinical Guideline 17: Dyspepsia: Managing Dyspesia in Adults in Primary Care. London: NICE; 2004.
   (view website)
5. Rampton DS. Regular review: management of Crohn's disease. BMJ 1999; 319: 1480-1485. (view website)
6. Ghosh S, Shand A, Ferguson A. Regular review: ulcerative colitis. BMJ 2000; 320: 1119-1123.
   (view website)
7. Carter MJ, Lobo AJ, Travis SPL. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 (Suppl V): v1-v16.
   (view website)
8. Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. Gut 2000; 46 (Suppl I): I1-I18.
   (view website)
9. National Institute for Clinical Excellence. Technology Appraisal 40: The Clinical Effectiveness and Cost Effectiveness of Infliximab for Crohn's Disease. London: NICE; 2002.
   (view website)
10. Mason P. Alcohol misuse - a case study. Pharm J 2003; 271: 777-779.
    (view website)
11. Thompson AD, Cook CH, Touquet R, Henry JA. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke's encephalopathy in the accident and emergency department. Alcohol Alcohol 2002; 37: 513-521.
    (view website)
12. Scottish Intercollegiate Guidelines Network. SIGN 74: The Management Of Harmful Drinking And Alcohol Dependence In Primary Care: A National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network; 2003.
    (view website)
13. Kennedy PT, O'Grady JG. Diseases of the liver: chronic liver disease. Hosp Pharm 2002; 9: 137-143.
    (view website)
14. Kriege JEJ, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Portal hypertension - 1: varices. BMJ 2001; 322: 348-351.
    (view website)
15. Kriege JEJ, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Portal hypertension - 2: ascites, encephalopathy, and other conditions. BMJ 2001; 322: 416-418.
    (view website)

Neurology and psychiatry

1. National Institute for Clinical Excellence. Clinical Guideline 23: Management of Depression in Primary and Secondary Care. London: NICE; 2004.
   (view website)
2. Burn D. Parkinson's disease: treatment. Pharm J 2000; 264: 476-479.
   (view website)
3. Chan KL, Jagait P, Tugwell C. Parkinson's disease - current and future aspects of drug treatment. Hosp Pharm 2004; 11: 18-22.
   (view website)
4. National Institute for Clinical Excellence. Clinical Guideline 20: The Epilepsies: the Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care. London: NICE; 2004.
   (view website)

General and surgical problems

1. Rahman M, Beattie J. Medication in the peri-operative period. Pharm J 2004; 272: 287-289.
   (view website)
2. Rahman M, Beattie J. Peri-operative care and diabetes. Pharm J 2004; 272: 323-325.
   (view website)
3. Rahman M, Beattie J. Peri-operative medication in patients with cardiovascular disease. Pharm J 2004; 272: 352-354.
   (view website)
4. Rahman M, Anson J. Peri-operative antibiotic prophylaxis. Pharm J 2004; 272: 743-745.
   (view website)
5. Rahman M, Beattie J. Drugs used to prevent surgical VTE. Pharm J 2004; 273: 717-719.
   (view website)
6. Rahman M, Beattie J. Post-operative nausea and vomiting. Pharm J 2004; 273: 786-788.
   (view website)
7. Rahman M, Beattie J. Managing post-operative pain. Pharm J 2005; 275: 145-148.
   (view website)
8. Murphy A, Scott A. Artificial nutritional support - what are the options? Hosp Pharm 2000; 7: 146-154.
   (view website)
9. Urie J, Fielding H, McArthur D, et al. Palliative care. Pharm J 2000; 265: 603-614.
   (view website)
10. Scottish Intercollegiate Guidelines Network. SIGN 44: Control of Pain in Patients with Cancer. Edinburgh: Scottish Intercollegiate Guidelines Network; 2000.
    (view website)
11. Haemostasis and Thrombosis Task Force for the British Committee for Standards in Haematology. Guideline. Guidelines on oral anticoagulation: third edition. Br J Haematol 1998; 101: 374-387.
    (view website)
12. British Society of Haematology. Guidelines on Oral Anticoagulation (Warfarin), 3rd edn, 2005 Update. London: British Society of Haematology; 2005.
    (view website)

Pharmaceutical problems

1. CSM Mersey. The burden of adverse drug reactions (ADRs). Mersey ADR Newsletter 25. Liverpool: CSM Mersey; 2005.
   (view website)
2. Cox A. Yellow card reporting scheme: what to report and where to. Tomorrow's Pharmacist 2005; 66-7.
   (view website)
3. Pirmohamed M, James S, Meakin S et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15-19.
   (view website)
4. Ferner R, Pirmohamed M. Monitoring drug treatment. BMJ 2003; 327: 1179-1181.
   (view website)
5. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Fortnightly review: Adverse drug reactions. BMJ 1998; 316: 1295-1298.
   (view website)
6. Medicines and Healthcare products Regulatory Agency/Committee on Safety of Medicines. The Yellow Card Scheme.
   (view website)
7. Thompson A. Back to basics: pharmacokinetics. Pharm J 2004; 272: 769-771.
   (view website)
8. Thompson A. Variability in drug dosage requirements. Pharm J 2004; 272: 806-808.
   (view website)
9. Thompson A. Why do therapeutic drug monitoring? Pharm J 2004; 273: 153-155.
   (view website)
10. Thompson A. Examples of dosage regimen design. Pharm J 2004; 273: 188-190.
    (view website)
11. Caldwell NA, Sexton J, Green CF. Pharmacokinetics is not a rare art but an essential tool for providing proper care. Pharm J 2001; 267: 50.
    (view website)
12. Nunney J, Raynor DK. Multi-compartment compliance aids: the fact and the fiction. Prescriber 2003; 14: 16-21.
    (view website)
13. Nunney J, Raynor DK. How are multi-compartment compliance aids used in primary care? Pharm J 2001; 267: 784-789.
    (view website)
14. Green CF, McCloskey S. UK survey of the provision of multi-compartment compliance aids and medicine reminder charts on discharge from hospital. Int J Pharm Pract 2005; 13: 85-90.
    (view website)
15. Department of Health. Management of Medicines - a resource to support implementation of the wider aspects of medicines management for the National Service Frameworks for Diabetes, Renal Services and Long-term Conditions. London: Department of Health; 2004.
    (view website)
16. Medicines Partnership website. What is Concordance?
    (view website)
17. United Kingdom Psychiatric Pharmacy Group/University of Aston. Expanded Medication History Form/Patient Interview. Birmingham: United Kingdom Psychiatric Pharmacy Group/University of Aston; 2001.
    (view website)
18. Medicines Partnership. Assessment Tool For Patients' Medicine-Taking Support Needs. London: Medicines Partnership; 2003.
    (view website)
19. Tulip SC, Cheung P, Campbell D, Walters P. Pharmaceutical care for older people: recording and review of medication following admission to hospital. Int J Pharm Pract 2002; 10(Suppl): R58.
    (view website)
20. Collins D, Nickless GD, Green CF. Medication histories: does anyone know what the patient should be taking? Int J Pharm Pract 2004; 12: 173-178.
    (view website)
21. Sexton J, Ho YJ, Green CF, Caldwell NA. Ensuring seamless care at hospital discharge: a national survey. J Clin Pharm Ther 2000; 25: 385-393.
    (view website)
22. Rose D, Evans SW, Williams R. Introducing a technician discharge prescription transcribing service. Hosp Pharm 2005; 12: 233-236.
    (view website)